// App-Quantinova.ai

2020 : Racial Differences in Prognostic Factors and Outcomes in Patients Undergoing Allogeneic Hematopoietic Cell Transplant

Researchers

Presenter

  • Lisa Rybicki

Principal Investigators

  • Mikkael A. Sekeres

  • Brian J. Bolwell

  • Matt Kalaycio

  • Rabi Hanna

  • Robert M Dean

  • Ronald Sobecks

  • Hien K. Duong

  • Brian T. Hill

  • Edward A. Copelan

Medical Centers

  • Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Cytomegalovirus infection

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 34

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved